Showing results (231-240 of 243) with videos related to
Sort By:
Pageof 25
The Journal of Rheumatology|July 2, 2004
Features associated with epilepsy in the antiphospholipid syndromeYehuda Shoenfeld, Shaul Lev, Ilan Blatt, et al.Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.Seminars in Arthritis and Rheumatism|June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohortMassimo Radin, Savino Sciascia, Doruk Erkan, et al.Autoimmunity Reviews|February 18, 2019
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive casesJaume Alijotas-Reig, Enrique Esteve-Valverde, Raquel Ferrer-Oliveras, et al.Seminars in Arthritis and Rheumatism|January 7, 2024
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")Cecile M Yelnik, Zeynep Belce Erton, Elodie Drumez, et al.Lupus|April 3, 2025
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry")Zeynep Belce Erton, Rebecca K Leaf, Danieli de Andrade, et al.Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.Arthritis Care & Research|February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and RepositoryYasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.Pageof 25